(NasdaqGM:APLT), NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ: APLT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Applied Therapeutics investors who were adversely affected by alleged securities fraud between […]

(NASDAQ:ASPI), NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in ASP Isotopes Inc. (“ASP Isotopes Inc.” or the “Company”) (NASDAQ: ASPI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of ASP Isotopes Inc. investors who were adversely affected by alleged securities

(NASDAQ:PCRX), NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Pacira BioSciences, Inc. (“Pacira” or the “Company”) (NASDAQ: PCRX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Pacira investors who were adversely affected by alleged securities fraud between August 2,

(NASDAQ:SAVA), NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Cassava Sciences, Inc. (“Cassava Sciences, Inc.” or the “Company”) (NASDAQ: SAVA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Cassava Sciences, Inc. investors who were adversely affected by alleged securities

(NASDAQ:REGN), NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ: REGN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Regeneron investors who were adversely affected by alleged securities fraud between November 2,

(NYSE:IIPR), NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Innovative Industrial Properties, Inc. (“Innovative Industrial Properties” or the “Company”) (NYSE: IIPR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Innovative Industrial Properties investors who were adversely affected by alleged

Clarra, a leading case management system crafted for litigation, and Legal Soft, recognized for its unparalleled support of legal practices with specialized Business Development, Marketing and Operations,proudly announce their strategic partnership. This alliance aims to equip litigation law firms with cutting-edge tools and services, ensuring operational simplicity, improved efficiency and enhanced visibility across all client

(NASDAQ:AZN), NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQ: AZN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of AstraZeneca investors who were adversely affected by alleged securities fraud between February 23, 2022

(NASDAQ:MQ), NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Marqeta, Inc. (“Marqeta” or the “Company”) (NASDAQ: MQ) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Marqeta investors who were adversely affected by alleged securities fraud between May 7, 2024

(NYSE:CUBI), NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Customers Bancorp, Inc. (“Customers Bancorp, Inc.” or the “Company”) (NYSE: CUBI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Customers Bancorp, Inc. investors who were adversely affected by alleged securities